MiMedx Group, Inc. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
MiMedx Group, Inc. (MDXG) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 27.46 million shares for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2024-02-28
- MiMedx Group, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2023 was 27.46M shares.
- MiMedx Group, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 0.00 shares.
- MiMedx Group, Inc. incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2021 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|
| 2023-12-31 | 27.46M shares 10-K · filed 2024-02-28 |
| 2022-12-31 | 0.00 shares 10-K · filed 2024-02-28 |
| 2021-12-31 | 0.00 shares 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |